Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Oncogene ; 23(25): 4400-12, 2004 May 27.
Artigo em Inglês | MEDLINE | ID: mdl-15077192

RESUMO

Indirubin, a bis-indole obtained from various natural sources, is responsible for the reported antileukemia activity of a Chinese Medicinal recipe, Danggui Longhui Wan. However, its molecular mechanism of action is still not well understood. In addition to inhibition of cyclin-dependent kinases and glycogen synthase kinase-3, indirubins have been reported to activate the aryl hydrocarbon receptor (AhR), a cotranscriptional factor. Here, we confirm the interaction of AhR and indirubin using a series of indirubin derivatives and show that their binding modes to AhR and to protein kinases are unrelated. As reported for other AhR ligands, binding of indirubins to AhR leads to its nuclear translocation. Furthermore, the apparent survival of AhR-/- and +/+ cells, as measured by the MTT assay, is equally sensitive to the kinase-inhibiting indirubins. Thus, the cytotoxic effects of indirubins are AhR-independent and more likely to be linked to protein kinase inhibition. In contrast, a dramatic cytostatic effect, as measured by actual cell counts and associated with a sharp G1 phase arrest, is induced by 1-methyl-indirubins, a subfamily of AhR-active but kinase-inactive indirubins. As shown for TCDD (dioxin), this effect appears to be mediated through the AhR-dependent expression of p27(KIP1). Altogether these results suggest that AhR activation, rather than kinase inhibition, is responsible for the cytostatic effects of some indirubins. In contrast, kinase inhibition, rather than AhR activation, represents the main mechanism underlying the cytotoxic properties of this class of promising antitumor molecules.


Assuntos
Quinases Ciclina-Dependentes/antagonistas & inibidores , Inibidores do Crescimento/farmacologia , Indóis/farmacologia , Receptores de Hidrocarboneto Arílico/efeitos dos fármacos , Animais , Ciclo Celular/efeitos dos fármacos , Proteínas de Ciclo Celular/biossíntese , Proteínas de Ciclo Celular/genética , Linhagem Celular Tumoral/efeitos dos fármacos , Inibidor de Quinase Dependente de Ciclina p27 , Ensaios de Seleção de Medicamentos Antitumorais , Fase G1/efeitos dos fármacos , Humanos , Indóis/química , Indóis/metabolismo , Ligantes , Neoplasias Hepáticas Experimentais/patologia , Camundongos , Dibenzodioxinas Policloradas/metabolismo , Dibenzodioxinas Policloradas/farmacologia , Ligação Proteica , Transporte Proteico/efeitos dos fármacos , Receptores de Hidrocarboneto Arílico/deficiência , Receptores de Hidrocarboneto Arílico/metabolismo , Relação Estrutura-Atividade , Proteínas Supressoras de Tumor/biossíntese , Proteínas Supressoras de Tumor/genética
2.
Toxicol Sci ; 65(2): 200-10, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11812924

RESUMO

The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor that mediates the toxic and biological effects of a variety of chemicals. Although halogenated and polycyclic aromatic hydrocarbons (HAHs and PAHs, respectively) represent the highest affinity and most toxic ligands, recent studies have demonstrated that the AhR can be activated by chemicals with structures distinctly different from HAHs/PAHs. In order to identify and characterize novel AhR ligands, we developed a rapid and inexpensive high-throughput screening bioassay based on the ability of AhR agonists to induce an HAH/PAH-responsive, enhanced green fluorescent protein (EGFP) reporter gene in a stably transfected mouse hepatoma (Hepa1c1c7) cell line. EGFP induction in the resulting recombinant cell line, H1G1.1c3, is sensitive (with a minimal 1-pM detection limit for 2,3,7,8-tetrachlorodibenzo-p-dioxin, the most potent AhR ligand), and it responds to HAHs and PAHs in a time-, dose-, and chemical-specific manner. Application of this bioassay was demonstrated by the rapid characterization of the relative inducing potency of a series of previously uncharacterized dioxin surrogates. This bioassay system has numerous advantages over currently available AhR-based bioassays including increased rapidity and ease of use, low reagent cost, and application for high-throughput screening.


Assuntos
Hidrocarbonetos Halogenados/farmacologia , Proteínas Luminescentes/biossíntese , Dibenzodioxinas Policloradas/farmacologia , Hidrocarbonetos Policíclicos Aromáticos/farmacologia , Receptores de Hidrocarboneto Arílico/agonistas , Animais , Sítios de Ligação , Bioensaio , Carcinoma Hepatocelular , Relação Dose-Resposta a Droga , Genes Reporter , Proteínas de Fluorescência Verde , Ligantes , Proteínas Luminescentes/genética , Camundongos , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Transfecção , Células Tumorais Cultivadas/efeitos dos fármacos
3.
Chem Biol Interact ; 141(1-2): 3-24, 2002 Sep 20.
Artigo em Inglês | MEDLINE | ID: mdl-12213382

RESUMO

The Ah receptor (AhR) is a ligand-dependent transcription factor that can be activated by structurally diverse synthetic and naturally-occurring chemicals. Although a significant amount of information is available with respect to the planar aromatic hydrocarbon AhR ligands, the actual spectrum of chemicals that can bind to and activate the AhR is only now being elucidated. In addition, the lack of information regarding the actual three-dimensional structure of the AhR ligand binding domain (LBD) has hindered detailed analysis of the molecular mechanisms by which these ligands bind to and active AhR signal transduction. In this review we describe the current state of knowledge with respect to naturally occurring AhR ligands and present and discuss the first theoretical model of the AhR LBD based on crystal structures of homologous PAS family members.


Assuntos
Receptores de Hidrocarboneto Arílico/agonistas , Receptores de Hidrocarboneto Arílico/metabolismo , Animais , Sítios de Ligação , Humanos , Ligantes , Ligação Proteica , Conformação Proteica , Transdução de Sinais
4.
Biofactors ; 20(1): 11-22, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15096657

RESUMO

In this study, we have compared the time and dose response curves for TCDD using the pGudLuc1.1-chemically activated luciferase expression (CALUX) cell bioassay and two new recombinant cell lines that contain a stably transfected mutated form of firefly luciferase reporter gene (pGudLuc6.1) or enhanced green fluorescent protein (EGFP) reporter gene (pGreen1.1). The time course of induction with pGudLuc1.1-containing H1L1.1c2 cells is transient, with maximal activity observed at 4 hours after treatment with 1 nM TCDD. In contrast, expression of luciferase from the pGudLuc6.1-containing H1L6.1c2 cells and the pGreen1.1-containing H1G1.1c3 cells progressively increases with time, with luciferase activity increasing at a significant faster rate than that of EGFP. Dose response analysis with each cell line at optimal analysis times reveal similar relative dose response curves and EC50s for H1L6.1c2 and H1G1.1c3 cells, while the EC50 for TCDD in the H1L1.1c2 cells was about 7-fold lower. In addition, these bioassay systems respond to halogenated and/or polycyclic aromatic hydrocarbons in a dose-specific manner. Given the above differences between cell lines and reporters, the choice of which cell line to use will certainly be dependent on the specific questions and issues being examined.


Assuntos
Dibenzodioxinas Policloradas/farmacologia , Receptores de Hidrocarboneto Arílico/agonistas , Animais , Bioensaio/métodos , Carcinoma Hepatocelular , Linhagem Celular Tumoral , Relação Dose-Resposta a Droga , Genes Reporter , Proteínas de Fluorescência Verde , Cinética , Neoplasias Hepáticas , Luciferases/efeitos dos fármacos , Luciferases/genética , Proteínas Luminescentes/efeitos dos fármacos , Proteínas Luminescentes/genética , Camundongos , Teratogênicos/farmacologia
5.
Biochem Biophys Res Commun ; 296(4): 799-805, 2002 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-12200118

RESUMO

Primary cultures of rat epidermal keratinocytes lose the ability to respond to chemicals with the induction of CYP1A1 gene expression after approximately 15 passages. This repression is mediated by a CT-rich direct repeat negative regulatory DNA (NeRD) element present in the upstream regulatory region of the CYP1A1 gene. Competitive gel retardation analysis using keratinocyte nuclear extracts and mutant NeRD oligonucleotides revealed the presence of two specific protein-NeRD complexes and revealed the specific nucleotides important for the formation of each complex. These studies demonstrate that these two factors bind to overlapping sites within the NeRD element. Nucleotide specificity of complex A formation is similar to that of previously identified nuclear silencing factors, while that of complex B appears to represent a unique CT-rich binding factor. These results suggest that repression of CYP1A1 gene expression in high passage keratinocytes may involve the interplay between at least two specific NeRD binding factors.


Assuntos
Núcleo Celular/metabolismo , Citocromo P-450 CYP1A1/genética , Animais , Sequência de Bases , Diferenciação Celular , Linhagem Celular , Fibroblastos/metabolismo , Humanos , Queratinócitos/metabolismo , Dados de Sequência Molecular , Mutação , Oligonucleotídeos/metabolismo , Oligonucleotídeos/farmacologia , Ligação Proteica , Ratos
6.
Annu Rev Pharmacol Toxicol ; 43: 309-34, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12540743

RESUMO

The induction of expression of genes for xenobiotic metabolizing enzymes in response to chemical insult is an adaptive response found in most organisms. In vertebrates, the AhR is one of several chemical/ligand-dependent intracellular receptors that can stimulate gene transcription in response to xenobiotics. The ability of the AhR to bind and be activated by a range of structurally divergent chemicals suggests that the AhR contains a rather promiscuous ligand binding site. In addition to synthetic and environmental chemicals, numerous naturally occurring dietary and endogenous AhR ligands have also been identified. In this review, we describe evidence for the structural promiscuity of AhR ligand binding and discuss the current state of knowledge with regards to the activation of the AhR signaling pathway by naturally occurring exogenous and endogenous ligands.


Assuntos
Fatores Biológicos/metabolismo , Receptores de Hidrocarboneto Arílico/metabolismo , Xenobióticos/metabolismo , Animais , Sítios de Ligação , Fatores Biológicos/química , Fatores Biológicos/farmacologia , Citocromo P-450 CYP1A1/biossíntese , Citocromo P-450 CYP1A1/genética , Regulação Enzimológica da Expressão Gênica , Humanos , Ligantes , Receptores de Hidrocarboneto Arílico/agonistas , Receptores de Hidrocarboneto Arílico/genética , Transdução de Sinais , Relação Estrutura-Atividade , Xenobióticos/química , Xenobióticos/farmacologia
7.
Biochemistry ; 41(3): 861-8, 2002 Jan 22.
Artigo em Inglês | MEDLINE | ID: mdl-11790108

RESUMO

The Ah receptor is a ligand-dependent transcription factor that mediates the biological and toxic effects of polycyclic aromatic hydrocarbons and halogenated aromatic hydrocarbons such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin). Recent evidence also suggests a role for the AhR in normal physiology and development. Although a variety of structurally diverse chemicals are reported to bind to and activate the AhR, the full spectrum of structural chemical classes that can interact with the AhR remains to be elucidated. Large-scale analysis of the ligand binding specificity of the AhR requires the use of a high-throughput AhR bioassay system for chemical screening. We have utilized a recombinant mouse hepatoma cell line (H1G1.1c3) containing a stably integrated TCDD- and AhR-responsive enhanced green fluorescent protein (EGFP) reporter gene to screen a 1,5-dialkylamino-2,4-dinitrobenzene combinatorial chemical library consisting of 155 parental amines and up to 12 090 combinatorial products in less than 7 days for novel AhR agonists. These analyses have identified numerous parental amines as relatively potent inducers of EGFP (with EC(50)s between 8 and 1000 microM) and also have revealed several novel products of the combinatorial chemical library synthesis with EC(50)s between 10 and 100 microM. Overall, these results have not only allowed the identification of novel activators of the AhR but also demonstrate the utility of the recombinant H1G1.1c3 cell bioassay for high-throughput chemical screening.


Assuntos
Receptores de Hidrocarboneto Arílico/agonistas , Animais , Sítios de Ligação , Bioensaio , Técnicas de Química Combinatória , Dioxinas/farmacologia , Genes Reporter , Proteínas de Fluorescência Verde , Ligantes , Neoplasias Hepáticas Experimentais , Proteínas Luminescentes/farmacologia , Camundongos , Dibenzodioxinas Policloradas/farmacologia , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/farmacologia , Transfecção , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA